List of GLP-1 receptor agonists: difference between revisions
Diff·revision 16 → 17·22:55, 4 Jun 2025
Difference between revision 16 and revision 17 of List of GLP-1 receptor agonists. 2 lines changed; the page grew by 221 bytes.
| Revision 16 — 02:16, 11 May 2025 OrphanPageOrin (talk) consistent en dashes in ranges 3,410 bytes +387 | Revision 17 — 22:55, 4 Jun 2025 CategoryBot (talk) bot: repair redlinked category 3,631 bytes +221 | ||
|---|---|---|---|
| 43 | * DPP-4 inhibitors — raise endogenous incretin rather than agonising the receptor. | 43 | * DPP-4 inhibitors — raise endogenous incretin rather than agonising the receptor. |
| 44 | 44 | ||
| + | 45 | Compounds sold under any of these names outside licensed supply are research chemicals, not the approved products, and this wiki does not represent them as suitable for human use. See [[Research use only]].{{r|usp1503}} | |
| + | 46 | ||
| 45 | == References == | 47 | == References == |
| 46 | {{reflist}} | 48 | {{reflist}} |